期刊
SEMINARS IN REPRODUCTIVE MEDICINE
卷 26, 期 5, 页码 401-410出版社
THIEME MEDICAL PUBL INC
DOI: 10.1055/s-0028-1087106
关键词
early pregnancy failure; miscarriage; spontaneous abortion; incomplete abortion; misoprostol
Medical management is gaining acceptance as a treatment option for women with early pregnancy failure (EPF). We reviewed randomized trials comparing misoprostol for EPF with surgical (dilation and curettage) or expectant management. Overall, similar to 85% of women with EPF can expect complete uterine evacuation after one or two doses of 600 or 800 mu g misoprostol without surgery. Medical management is safe. As with Surgical therapy, serious complications are rare. Women undergoing medical management of EPF may expect moderate pain and bleeding for several days, which may persist for 2 weeks or longer. Side effects associated with misoprostol are common; however, acceptability of medical management remains high.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据